Abstract: Descending control of nociceptive processing in the rostral ventromedial medulla (RVM) has been implicated in the inhibition and facilitation of spinal nociceptive transmission. Here we investigated the contribution of serotonergic (5-HT) pathway at the RVM to pruritic behavior. Selective lesion of the descending serotonergic pathway by intra-RVM injection of focal neurotoxin 5,7-dihydroxytryptamine (2 µg/0.5 µl) attenuated pruritic behavior at the 30-min observation period following an intradermal microinjection of compound 48/80 (100 µg/100 µl) in the nape of the neck. Intradermal microinjection of compound 48/80 resulted in a dramatic increase in itch behavior between naive group and saline group. 5,7-DHT-treated mice showed profound scratching deficits after intradermal injection of compound 48/80. 5,7-DHT treatment resulted in a significant decrease in the number of 5-HT positive neurons in the RVM by using intracisternal injection of the serotonin neurotoxin 5,7-DHT. These findings demonstrate that pruritic behavior is dependent in part on descending facilitation via the RVM, and identify a modulatory role of serotonergic pathway at the RVM for pruritic behavior.
Introduction
Itch has been defined as an unpleasant skinspecific sensation with negative affective component, and produces a characteristic desire or reflex of scratching behavior [1] [2] [3] . The mechanisms that generate itch are poorly understood and effective treatment for chronic itch is lacking despite its clinical importance. It's widely acknowledged that both pain and itch belong to nociceptive sensation [4] , and many C-fibers respond both to algesic (pain-inducing) and pruritic (itch-inducing) compounds [5, 6] . The rostral ventromedial medulla (RVM) of the brainstem is a prominent component of the descending modulatory system for nociception at the spinal cord level, and neurons in the RVM have been implicated in the inhibition and facilitation of spinal nociceptive transmission [7] [8] [9] [10] . Recent studies have established that the RVM facilitation of nociceptive transmission in the spinal cord contributes to neuropathic pain [8, [11] [12] [13] . Thereby, it has been hypothesized that RVM facilitation of nociceptive transmission might involve in chronic pathological itch.
Behavioral data suggest that scratching behavior may be used as an index for the study of itch in experimental rodents [2, 14] . Several lines of evidence suggested that 5, 7-dihydroxytriptamine (5,7-DHT), a serotonergic neurotoxin, selectively diminished tissue 5-HT content [15] [16] [17] . To date, the role of descending facilitation in pruritic behavior has not been investigated. Here, it was reported that the changes of scratching behaviors induced by histaminedependent pruritogen compound 48/80 after selectively ablated serotonergic signals at the RVM in mice.
Methods and materials

Animal care
Male C57BL/6J mice (8-10 weeks old) at the time of surgery were maintained in a climate-controlled room on a 12-hlight/dark cycle (light on at 07:00 h). Mice were housed (5/cage), but they were individually caged during each experiment. Food and water were available ad libitum. All testing and surgeries were performed in accordance with the policies and recommendations of the National Guides for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Experimental design
Mice were randomly assigned to one of three groups for these experiments: (1) naive group (naive group, n = 6); (2) saline group (saline group, n = 6); (3) 5,7-DHT group (DHT group, n = 6). 0.5 µl saline was microinjected into the RVM in saline group whereas 0.5 µl 5,7-DHT (2 µg/0.5 µl) into the RVM in DHT group. 10 d after surgical procedures, pruritic behavior was measured. All procedures and behavioral assay were conducted in an isolated quiet room to reduce variance.
Intra-RVM microinjections
As previously described [8] , mice were anesthetized with 2% Sodium pentobarbital (50 mg/kg) and placed in a stereotaxic instrument. The coordinates for the RVM were as follows: 5.8-6.0 mm caudal to bregma, midline, and 5.5-5.7 mm ventral to the surface of the cerebellum (Franklin and Paxinos, 2007) [18] . A midline incision was made to expose the skull with a dental drill to insert a microinjection needle into the RVM. Microinjections were performed by delivering 5,7-DHT (2 µg/0.5 µl) or saline (0.5 µl) slowly over a 10 min period using a 0.5 µl Hamilton syringe with a 32 gauge needle. To prevent damage of noradrenergic neurons in the RVM, desipramine (20 mg/kg, i.p.), an inhibitor of neuronal noradrenergic reuptake, was pretreated animals 30 min before 5,7-DHT (or saline) administration [7] . The wound was closed and animals returned to their cages after they recovered from anesthesia.
Behavioral assay
Ten d after Intra-RVM microinjections, pruritic behavior was evaluated. The mice were adapted to the testing situation for at least 15 min. They were anesthetized with isoflurane and received an intradermal microinjection of 100 µL compound 48/80 (100 µg/100 µl) or saline in the nape of the neck. As previously described [16, 17] , immediately after the injection, the mouse was placed into the arena and videotaped from above for 30 min. Videotapes were reviewed by the observers of the pruritic behaviors. All investigators were blind to the treatment of the mice, and the number of scratch bouts was recorded at 5 min intervals. All pruritic behavior was evaluated as previously described [10, 17, 18] with minor modifications.
Histology
After performing the behavioral assay, the animals were deeply anesthetized with ketamine and xylazine. Then, they were transcardially perfused with 0.9% saline and 4% PFA solution as described [2, [19] [20] [21] . The brains were dissected and immersed in the same fixative for 2h at 4°C. Subsequently, the brains were immersed in 30% sucrose overnight at 4°C. Free-floating sections (30 μm) were made at the levels of the target site and stored at -80°C until staining. The neuroanatomical locations of the target site were confirmed using mouse brain atlas. Only the animals with correct target site in the RVM were included in the data analysis.
For the 5-HT staining, sections were washed with 0.01 M PBS (3 × 10 min) before being incubated primary with rabbit anti-5-HT (1:2000) and secondary with donkey anti-rabbit 5-HT (1:1000). Finally, sections were collected onto glass microscope slides, covered with a coverslip, and examined under the fluorescence microscopy by an investigator blinded as to treatment.
Statistical analysis
All the data were presented as _ x ± s or _ x ± s x . Two-way repeated-measures ANOVA was used to analyze the data with multiple time points (time course of itch behaviors). A P value of < 0.05 was considered statistically significant.
Results
Grouping and evaluation
In the RVM area by saline or focal neurotoxin 5,7-DHT (2 µg/0.5 µl) injection, we evaluated scratching behaviors of mice response to intradermal injection of compound 48/80 (100 µg/100 µl), a histamine-dependent pruritogen-ic agent. Unlike the saline-treated and naïve mice, which exhibited vigorous scratching response after intradermal injection of compound 48/80, 5,7-DHT-treated mice showed profound scratching deficits (reduced by 77%) ( Figure 1A and 1B) .
5-HT immunoreactivity in the RVM 10 d after intra-RVM microinjections
We found that 5,7-DHT treatment resulted in a significant decrease in the number of 5-HT positive neurons in the RVM by using intracisternal injection of the serotonin neurotoxin 5,7-DHT.
5-HT positive neurons in the RVM (including nucleus raphe magnus (NRM) and the adjacent gigantocellularreticular nucleus α part (NGCα) were widely expressed between naive group and saline group. 5-HT expression between the NRM and NGCα was significantly decreased in DHT group (n = 6) ( Figure 2A ) compared to saline group (n = 6) ( Figure 2B ).
Discussion
In the present study, we used intra-RVM microinjections and fluorescence immunohistochemistry, and assessed the contribution of the RVM 5-HT system to descending itch modulation by examining pruritic behavior in the histaminedependent pruritogenic model. The principal findings we made were as follow: (1) Intradermal microinjection of compound 48/80 resulted in a dramatic increase in itch behavior between naive group and saline group; (2) 5,7-DHTtreated mice showed profound scratching deficits after intradermal injection of compound 48/80; (3) 5,7-DHT treatment resulted in a significant decrease in the number of 5-HT positive neurons in the RVM by using intracisternal injection of the serotonin neurotoxin 5,7-DHT.
Anatomical and physiological studies have shown that serotonergic (5-HT) system comprises one of the major components of descending pain control pathways [22] . In addition to this finding, serotonergic projection has been shown to inhibit nociceptive afferents at the level of the spinal dorsal horn neurons [23, 24] . There is growing recognition that serotonergic neurons play a complex and crucial role as an underlying neurobiological mechanism to modulate acute and chronic pain [25] [26] [27] . Braz et al [28] used a transgenic line of mice in which Cre recombinase is selectively expressed in 5-HT neurons (ePet-Cre mice), and had shown an anatomical substrate that a noxious stimulus can activate 5-HT neurons of the NRM and in turn could trigger descending serotonergic antinociceptive controls. Thereby, it is speculated that serotonergic signaling in RVM may modulate itch-related responses. Our results may confirm this hypothesis, and provide a novel exploration of mechanism for pruritic signal pathway.
The present data provide the experimental evidence for behavioral reduction of itch-related scratching after selectively ablated serotonergic signals at the RVM, potentially mediated via sensitization of central pruritogen-sensitive signals. This method will be proved for future studies of transmission mechanisms of itch signal and potential treatment of chronic itch.
